MAP1B and fragile X syndrome: Quantitative polymerase chain reaction (qPCR) analysis showed that MAP1B mRNA levels were higher in two FXS PSC lines (FXS1, FXS2) compared to two control (Ctrl1, Ctrl6) PSC lines (Supplementary Fig. 1g).